Dr Art Walaszek joins Ethics Talk to discuss his article, coauthored with Drs William Smith and David Elkin: “How to Draw on Narrative to Mitigate Ageism.”
A physician argues against the use of placebo medications in routine clinical care situations where the medication may be warranted but the patient has not been fully informed about the treatment.
The neurodiversity movement challenges us to rethink autism through the lens of human diversity, valuing diversity in neurobiologic development as we would value it in gender, race, ethnicity, religion, or sexual orientation.
A judicious approach to autism would be to replace a “disability” or “illness” paradigm with a “diversity” perspective that takes into account both strengths and weaknesses and the idea that variation can be positive in and of itself.
AMA J Ethics. 2015;17(4):348-352. doi:
10.1001/journalofethics.2015.17.4.msoc1-1504.
Although now discredited, the idea that mothers’ behavior is responsible for autism lives on in the social pressure that mothers feel to save their autistic children, at a cost to both the self-blaming parents and people with autism.
AMA J Ethics. 2015;17(4):353-358. doi:
10.1001/journalofethics.2015.17.4.mhst1-1504.
Because many complementary and alternative medicine therapies for autism are based on misguided notions of its cause and lack support from scientifically sound studies, physicians should steer parents away from these practices and toward safe, effective, and evidence-based interventions.
AMA J Ethics. 2015;17(4):375-380. doi:
10.1001/journalofethics.2015.17.4.sect2-1504
There is evidence that some complementary and alternative treatments improve physiological abnormalities in autism and thus hold promise for improving symptoms.
AMA J Ethics. 2015;17(4):369-374. doi:
10.1001/journalofethics.2015.17.4.sect1-1504.